A randomized, multicenter trial evaluating the efficacy for early use of PCSK9 inhibitors before primary percutaneous coronary intervention in patients with Acute Myocardial Infarction
Latest Information Update: 02 Dec 2020
At a glance
- Drugs Alirocumab (Primary) ; Evolocumab (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Acronyms PCSK9-PAMI trial
- 02 Dec 2020 New trial record